Integra LifeSciences enters $150M accelerated share repurchase agreement with Goldman Sachs

INTEGRA LIFESCIENCES HOLDINGS CORP

Repurchase of $150M of common stock via accelerated share repurchase with Goldman Sachs & Co. LLC.
Transactions expected to be completed in the first half of 2023.
Shares have par value $0.01 per share; program reduces outstanding shares.

item 8.01

INTEGRA LIFESCIENCES HOLDINGS CORP filing history →

Source: SEC EDGAR

accession 0001193125-23-016584

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.